By Lisa Kerner
Charlotte, N.C., June 20 - Perceptronix Medical Inc. said it completed a C$5.5 million round of private financing.
Proceeds will be used as a bridge to an anticipated larger follow-on private placement.
"This is a very exciting time in the life of Perceptronix which is now in transition from development to commercialization, having received regulatory approvals for a number of our products in North America and Europe in the past four months," chairman and chief executive officer Milton Wong said in a company news release.
British Columbia Investment Management Corp. joined other new and existing investors in the financing.
Perceptronix is a cancer diagnostics company based in Vancouver, B.C.
| Issuer: | Perceptronix Medical Inc.
|
| Issue: | Private financing
|
| Amount: | C$5.5 million
|
| Investors: | British Columbia Investment Management Corp., new and existing investors
|
| Announcement date: | June 20
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
